AR083723A1 - HEPATITIS C VIRUS INHIBITORS - Google Patents
HEPATITIS C VIRUS INHIBITORSInfo
- Publication number
- AR083723A1 AR083723A1 ARP110102005A ARP110102005A AR083723A1 AR 083723 A1 AR083723 A1 AR 083723A1 AR P110102005 A ARP110102005 A AR P110102005A AR P110102005 A ARP110102005 A AR P110102005A AR 083723 A1 AR083723 A1 AR 083723A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- compounds
- hepatitis
- virus inhibitors
- alkoxyalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Sales de estos farmacéuticamente aceptables; composiciones que contienen dichos compuestos; y uso de dichos compuestos como inhibidores de la replicación de VHC.Reivindicación 1: Un compuesto caracterizado porque es seleccionado de los compuestos de formula (1) ó (2), o una sal de éste farmacéuticamente aceptable, en donde R1 es H; cada R2 se selecciona, independientemente, de H, alquilo C1-4, halógeno y alcoxialquilo C1-4; alquilo C1-4 se sustituye, opcionalmente, con NRcRd; cada Rc y Rd se selecciona, independientemente, de H, alquilo C1-4, alcoxialquilo C1-4, alquilcarbonilo C1-4 y alcoxicarbonilo C1-4; y cada R3 es, independientemente, alcoxi C1-4.Pharmaceutically acceptable salts thereof; compositions containing said compounds; and use of said compounds as inhibitors of HCV replication. Claim 1: A compound characterized in that it is selected from the compounds of formula (1) or (2), or a pharmaceutically acceptable salt thereof, wherein R1 is H; each R2 is independently selected from H, C1-4 alkyl, halogen and C1-4 alkoxyalkyl; C1-4 alkyl is optionally substituted with NRcRd; each Rc and Rd is independently selected from H, C1-4 alkyl, C1-4 alkoxyalkyl, C1-4 alkylcarbonyl and C1-4 alkoxycarbonyl; and each R3 is independently C1-4 alkoxy.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35338810P | 2010-06-10 | 2010-06-10 | |
| US37092210P | 2010-08-05 | 2010-08-05 | |
| US38483110P | 2010-09-21 | 2010-09-21 | |
| US38608810P | 2010-09-24 | 2010-09-24 | |
| US201061424119P | 2010-12-17 | 2010-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR083723A1 true AR083723A1 (en) | 2013-03-20 |
Family
ID=44315035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110102005A AR083723A1 (en) | 2010-06-10 | 2011-06-09 | HEPATITIS C VIRUS INHIBITORS |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR083723A1 (en) |
| WO (1) | WO2011154871A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8552047B2 (en) | 2011-02-07 | 2013-10-08 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US9546160B2 (en) | 2011-05-12 | 2017-01-17 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US9326973B2 (en) | 2012-01-13 | 2016-05-03 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US20150023913A1 (en) | 2013-07-02 | 2015-01-22 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
| US9717712B2 (en) | 2013-07-02 | 2017-08-01 | Bristol-Myers Squibb Company | Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus |
| EP3021845A1 (en) | 2013-07-17 | 2016-05-25 | Bristol-Myers Squibb Company | Combinations comprising biphenyl derivatives for use in the treatment of hcv |
| WO2017023631A1 (en) | 2015-08-06 | 2017-02-09 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0166088B1 (en) | 1990-01-23 | 1999-01-15 | . | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| GB9518953D0 (en) | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| WO2000035296A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Improved release of medicament active agents from a chewing gum coating |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| US7759495B2 (en) * | 2006-08-11 | 2010-07-20 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| JP5314053B2 (en) * | 2008-02-12 | 2013-10-16 | ブリストル−マイヤーズ スクイブ カンパニー | Hepatitis C virus inhibitor |
-
2011
- 2011-05-31 WO PCT/IB2011/052392 patent/WO2011154871A1/en active Application Filing
- 2011-06-09 AR ARP110102005A patent/AR083723A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011154871A1 (en) | 2011-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR083723A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
| AR077548A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
| CR20150085A (en) | NEW 6-AMINO ACID-HETEROARILDIHYDROPIRMIDINDAS FOR THE TREATMENT AND PROFILAXIS OF HEPATITIS B VIRUS INFECTION | |
| AR076900A1 (en) | USEFUL NITROGEN HETEROCICLIC DERIVATIVES AS ANTIVIRAL AGENTS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME AS HCV INHIBITORS | |
| CO7160104A2 (en) | Hepatitis C virus inhibitors | |
| ECSP15000435A (en) | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | |
| NI201200192A (en) | DERIVATIVES OF IMIDAZOPYRIDINE, ITS PREPARATION PROCEDURE AND ITS APPLICATION IN THERAPEUTICS. | |
| AR085327A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
| CO6561783A2 (en) | FLAVIVIRIDAE VIRUS INHIBITORS | |
| ECSP12011684A (en) | FLAVIVIRIDAE VIRUS INHIBITORS. | |
| CO7240410A2 (en) | Macrocyclic inhibitors of flaviviridae virus | |
| AR097866A1 (en) | 4-AZAINDOL DERIVATIVES | |
| NI201200191A (en) | INDOLIZINE DERIVATIVES, ITS PREPARATION PROCEDURE AND ITS APPLICATION IN THERAPEUTICS | |
| AR085607A1 (en) | MST1 QUINASA INHIBITORS AND METHODS FOR USE | |
| AR085852A1 (en) | QUINASE INHIBITORS RELATED TO PIRROLO [2,3-D] TROPOMIOSINE PYRIMIDINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| ECSP12012104A (en) | VIRUS FLAVIVIRIDAE INHIBITORS | |
| AR072726A1 (en) | DERIVATIVES OF INDOL MACROCICLIC USEFUL AS INHIBITORS OF THE VIRUS OF HEPATITIS C | |
| PE20142081A1 (en) | QUINURENIN-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF USE OF THEM | |
| CO2019004978A2 (en) | Therapeutic compounds and methods to use them | |
| AR093758A1 (en) | ARIL LACTAMA QUINASA INHIBITORS | |
| AR087487A1 (en) | HETEROCICLIC COMPOUNDS DERIVED FROM PYRIMIDINE AS INHIBITORS OF THE JANUS ACTIVATED KINASES (JAK) | |
| NI201200002A (en) | NEW DERIVATIVES OF (6-OXO-1,6-DIHIDRO-PIRIMIDIN-2-IL) -AMIDE, ITS PREPARATION AND ITS PHARMACEUTICAL USE AS PHOSPHORILATION INHIBITORS OF AKT (PKB). | |
| ES2571577T3 (en) | Novel morpholinyl derivatives useful as MOGAT-2 inhibitors | |
| AR091520A1 (en) | PYRANOPIRIDONE INHIBITORS OF TANQUIRASA | |
| AR091888A1 (en) | UREA COMPOUNDS AND ITS USE AS ENZYMES INHIBITORS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |